Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis

Tropical Medicine and International Health

Volumn 16, Issue 9, 2011, Pages 1112-1119

  Anto, Francis ^a   Asoala, Victor ^a   Anyorigiya, Thomas ^a   Oduro, Abraham ^a   Adjuik, Martin ^a   Akweongo, Patricia ^a   Aborigo, Raymond ^a   Bimi, Langbong ^b   Amankwa, Joseph ^c   Hodgson, Abraham ^a  

^a NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c GHANA HEALTH SERVICE   (Ghana)

Author keywords

Albendazole; Ivermectin; Lymphatic filariasis; Onchocerciasis; Praziquantel; Schistosomiasis

Indexed keywords

ALBENDAZOLE; HEMOGLOBIN; IVERMECTIN; PRAZIQUANTEL;

ANTHROPOLOGY; CHILD HEALTH; COMPARATIVE STUDY; ENDEMIC SPECIES; FILARIASIS; HEALTH EDUCATION; HEALTH IMPACT; HEMATOLOGY; IVERMECTIN; ONCHOCERCIASIS; PARASITOLOGY; SCHISTOSOMIASIS;

ARTICLE; BODY HEIGHT; CHILD; CHILD HOSPITALIZATION; COMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ENDEMIC DISEASE; FEMALE; GHANA; HEADACHE; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFORMATION PROCESSING; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; ONCHOCERCIASIS; PARASITE PREVALENCE; PRESCHOOL CHILD; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL CHILD; SCHOOL HEALTH EDUCATION; VOLUNTEER; WEAKNESS;

ADOLESCENT; ALBENDAZOLE; CHILD; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; FEMALE; FILARICIDES; GHANA; HEALTH EDUCATION; HUMANS; IVERMECTIN; MALE; ONCHOCERCIASIS; PRAZIQUANTEL; RURAL POPULATION; SCHISTOSOMIASIS;

GHANA;

SCHISTOSOMA HAEMATOBIUM;

EID: 79961172736     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2011.02814.x     Document Type: Article

References (20)

1. Agnew-Blais J, Carnevale J, Gropper A, Shilika E & Bail RNgoma M (2010) Schistosomiasis haematobium prevalence and risk factors in a school-age population of peri-urban Lusaka, Zambia. Journal of Tropical Pediatrics 56, 247-253.
2. Amankwa JA, Bloch P, Meyer-Lassen J, Olsen A & Christensen NO (1994) Urinary and intestinal schistosomiasis in the Tono Irrigation Scheme, Kassena/Nankana District, upper east region, Ghana. Tropical Medicine and Parasitology 45, 319-323.
3. Awumbila M & Ardayfio-Schandorf E (2008) Gendered poverty, migration and livelihood strategies of female porters in Accra, Ghana. Norwegian Journal of Geography 62, 171-179.
4. Cantey PT, Rout J, Rao G, Williamson J & Fox LM (2010). Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Neglected Tropical Diseases 4, e728. doi:.
5. Gyapong JO, Magnussen P & Binka FN (1994) Parasitilogical and Clinical aspects of bancroftian filariasis in Kassena-Nankana District. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 555-557.
6. Gyapong M, Gyapong JO & Owusu-Banahene G (2001) Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Annals of Tropical Medicine and Parasitology 95, 77-86.
7. Katabarwa M, Habomugisha P, Eyamba A, Agunyo S & Mentou C (2010) Monitoring ivermectin distributors involved in integrated health care services through community-directed interventions-a comparison of Cameroon and Uganda experiences over a period of three years (2004-2006). Tropical Medicine and International Health 15, 216-223.
8. King CH, Dickman K & Tisch DJ (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disabilityrelated outcomes in endemic schistosomiasis. Lancet 365, 1561-1569.
9. Mohammed KA, Haji HJ, Gabrielli AF et al. (2008) Triple coadministration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. PLoS Neglected Tropical Diseases 2, e171.
10. Na-Bangchang K, Kietinun S, Pawa KK, Hanpitakpong W, NaBangchang C & Lazdins J (2006) Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 335-345.
11. Namwanje H, Kabatereine N & Olsen A (2011). A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 105, 181-188.
12. Navrongo Demographic Surveillance SystemAnnual report 2009.
13. Ndiaye D, Diouf M, Diedhiou Y, Toure M, Sembene M & Ndir O (2005) Prevalence of urinary schistosomiasis in the school population in Senegal in 2002. Dakar Medical 50, 198-201.
14. Ndyomugyenyi R & Kabatereine N (2003) Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages. Tropical Medicine and International Health 8, 997-1004.
15. Ndyomugyenyi R, Lakwo T, Habomugisha P & Male B (2007) Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward. Annals of Tropical Medicine and Parasitology 101, 323-333.
16. Remme J, Baker RH, De Sole G et al. (1989) A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. Tropical Medicine and Parasitology 40, 367-374.
17. Richards FO Jr, Eigege A, Miri ES, Jinadu MY & Hopkins DR (2006) Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis. Bulletin of the World Health Organization 84, 673-676.
18. Webbe G (1999) Community-wide treatment of schistosomiasis with praziquantel. Tropical Doctor 29, 172-176.
19. WHO (1998) Guidelines for the Evaluation of Soil-Transmitted Helminthiasis and Schistosomiasis at Community Level. (WHO/CTD/SIP/98.1). WHO, Geneva.
20. WHO (2002) Report of the WHO Informal Consultation on the use of Praziquantel during pregnancy/lactation and Albendazole/Mebendazole in Children under 24months. Geneva, 8-9 April 2002.